RPAM
IDIX

Rhenman & Partners Asset Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-97,100
Closed -$2.34M – 105
2014
Q2 		$2.34M Buy
+97,100
New +$1.01M 0.69% 54

Rhenman & Partners Asset Management's IDIX Position: Q3 2014 in Review

Rhenman & Partners Asset Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 97,100 shares — an estimated $2.34M sold.

Rhenman & Partners Asset Management first reported a position in IDIX in Q2 2014 and held it in 1 quarter. The position peaked at $2.34M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • Rhenman & Partners Asset Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 97,100 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $2.34M.
  • Rhenman & Partners Asset Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2014 and held it in 1 quarter.
  • Rhenman & Partners Asset Management's IDENIX PHARMACEUTICALS INC position peaked at $2.34M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2014, filed 3 Nov 2014.